Proteome Sciences (LON:PRM) Stock Price Down 2.7% – What’s Next?

Shares of Proteome Sciences plc (LON:PRM) were down 2.7% during mid-day trading on Tuesday . The stock traded as low as GBX 3.60 ($0.05) and last traded at GBX 3.60 ($0.05). Approximately 1,183,886 shares changed hands during trading, an increase of 573% from the average daily volume of 175,815 shares. The stock had previously closed at GBX 3.70 ($0.05).

Proteome Sciences Price Performance

The company has a 50 day moving average of GBX 4.08 and a two-hundred day moving average of GBX 3.46. The firm has a market cap of £8.54 million, a P/E ratio of -2.09 and a beta of 0.07. The company has a quick ratio of 0.37, a current ratio of 0.20 and a debt-to-equity ratio of -258.66.

Proteome Sciences (LON:PRM) last released its earnings results on Thursday, April 10th. The company reported GBX (1.15) (($0.01)) EPS for the quarter. Proteome Sciences had a negative net margin of 0.04% and a negative return on equity of 0.01%.

About Proteome Sciences

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.